Exploring the Effect of Combined Chinese and Western Treatment on Home Medical Care

Hypertension Clinical Trial

Official title:

Effectiveness of Combining Antihypertensive Drugs and Acupuncture on Isolated Systolic Hypertension of Elderly Patients at Home

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03600220
• Other study ID #: TCHIRB-10703120-E
• Status: Enrolling by invitation
• Phase: N/A
• Start date: June 1, 2018
• Est. completion date: May 31, 2019

Study information

• Verified date: June 2018
• Source: Taipei City Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

combine antihypertensive drugs and acupuncture to isolated systolic hypertension elderly patients at home

Description:

The investigators would like to compare the effectiveness of acupuncture and drug therapy on blood pressure.

The investigators chose acupuncture point according the Traditional Chinese Medicine theory, besides, each patient was using 1-3 antihypertensive drug of a heterogeneous pharmacological group ranging from angiotensin-converting enzyme inhibitor (ACE inhibitor), diuretics, and beta blockers.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 80
• Est. completion date: May 31, 2019
• Est. primary completion date: September 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

1. patient with isolated blood pressure diagnosis by physicians and BP >140/<90 mmHg

2. patient took the drug to control blood pressure for more than one year

3. age>65 years old

4. Willing to participate in this study

Exclusion Criteria:

1. Suspected acute stroke

2. chest pain or dyspnea

3. ingestion of short-acting antihypertensive medication within 2 h prior to the beginning of the study

4. body temperature >37.5°C(99.5°F)

Related Conditions & MeSH terms

• Hypertension

Intervention

Other:
• acupuncture
antihypertension drug, acupuncture twice a week for 3 months

Locations

Country	Name	City	State
Taiwan	Taipei City Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
Taipei City Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood pressure	measure blood pressure after the treatment compare the initial blood pressure	change from Baseline Systolic Blood Pressure at 3 months
Secondary	Traditional Chinese Medicine constitution	use The Constitution in Chinese Medicine Questionnaire	use the questionnaire at Baseline, 1.5 month, and three month later
Secondary	heart rate variability	use autonomic nervous system (ANS) watch to monitor patient's heart rate variability, Low Frequency/High Frequency ratio	use ANS watch to monitor patient's condition at Baseline, 1.5 month, and three month later